Clinical Trial Update: Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital [Phase 3]

View source ↗

Summary

Phase 3 historical control study of the Ologen collagen matrix implant (Oculusgen) for glaucoma and pterygium in China; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Pterygium

Drugs mentioned

• Ologen

Snippet

Sponsor: Pro Top & Mediking Company Limited | Conditions: Glaucomas, Pterygium | Phase 3 | Status: UNKNOWN